MYM Nutraceuticals is focused on constructing high quality cannabis growing facilities while building, acquiring, and growing businesses to become a world-class cannabis brand.
MYM through its various joint ventures is currently building three large-scale production facilities in both Canada and Australia. Upon completion of these three projects, the total amount of greenhouse growing space is expected to exceed 2.7 million square feet.
The Weedon Project
The Weedon Project – The 1.5 million sf greenhouse project has been approved by the City of Weedon. A license application has been submitted to Health Canada. MYM has purchased through its partially owned subsidiaries 329 acres of land to build on. This project will include a cannabis museum and a cannabis university for industry training.
The Laval Project
The Laval Project – The facility has been completed and is awaiting licensing from Health Canada. The facility is currently 10,000 sf and will be expanded to 37,000 sf. Once the appropriate licenses are received from Health Canada, it will enable MYM to produce and market its branded THC and CBD medical products across Canada.
The Northern Rivers Project
Casino, New South Wales, Australia
The Northern Rivers Project owned by Solaris Nutraceuticals – a 1.2 million sf greenhouse project which, upon completion, is expected to be the largest cannabis greenhouse in Australia. Subject to receiving the appropriate licenses, the first crop is expected to be planted in the second quarter of 2019. Solaris Nutraceuticals received a AUD $2,500,000 grant from Federal Department of Innovation, Industry & Science for this project. MYM owns 35% of Solaris Nutraceuticals – www.solarisnutraceuticals.com
MYM has purchased a 49% stake in Colombia ORGANICA, a Colombia based company with expertise in the manufacturing of pharmaceutical products, medicinal chemical substances and botanical products. Colombia ORGANICA holds a seed to sale license for low THC cannabis and is in the application process for both high THC cannabis cultivation and extraction. Colombia ORGANICA has existing licensing permits to grow, produce and create cannabis derivatives to be commercialized and/or exported. The company will continue to focus on production of high quality plants that are suited to the unique high altitude, equatorial regions of Antioquia, Colombia. Colombia ORGANICA is in the process of developing and registering seed strains with the Colombia Agriculture Institute.
MJT Manufacturing Project – the 5,000 SF production facility located in Toronto, Ontario is a GMP certified, state of the art extraction lab and production facility dedicated to industrial hemp processing (CBD). This high capacity production space is able to produce large volumes with a high level of consistency. The facility is capable of producing a full range of CBD extracts and isolates. The MJT production facility is focussed on product development for MYM owned brand.
Erick Factor | Executive Chairman
Mr. Erick Factor has been appointed to the Company’s Board of Directors and will also serve as Executive Chairman. Mr. Factor is a well-known expert in the cannabis industry and has 20 years of experience in cultivating medical marijuana and manufacturing cannabis by-products, and has provided medical marijuana to thousands of patients over the past two decades. Mr. Factor is also the founder of the “Westcoast Medicann” dispensary, one of just a handful of dispensaries in Vancouver to be licensed under the City of Vancouver’s stringent bylaws. He has extensive experience working with Health Canada, from whom he has obtained MMAR and MMPR licenses for hundreds of patients, and has managed and operated grow facilities to produce for those patients. Mr. Factor has also gained invaluable experience over the past three years in ACMPR licensing regulations and applications.
Howard Steinberg | Vice-Chairman & Independant Director
Mr. Steinberg has more than 20 years investment experience as a senior executive, working within some of the largest financial institutions in the world. He has sat on over a dozen Boards including his current role as Executive Chairman of Parallax Developments Corp. He has invested personally and with global financial institutions in a wide range of industries in every area of the balance sheet. Mr. Steinberg has an MBA from the University of Western Ontario and is a CFA charterholder.
Rob Gietl | CEO & Director
Mr. Gietl was most recently the Director of Business Development at NRI Global Inc. where he headed up multi-million dollar industrial acquisitions, environmental remediation and global sales of reusable assets and commodities. His skills in negotiations and plan development enabled him to leverage partnerships to accelerate expansion and facilitate synergy in execution. Mr. Gietl is well known for his ability to exponentially grow businesses including the west coast franchise expansion of Dominos Pizza, where he Consistently grew the annual business to achieve 300+% increases year over year. Mr. Gietl is a seasoned Business Development and Operations executive with a diverse track record of leading change across all areas of concept creation, brand re-positioning, market penetration, fiscal accountability and efficient execution of business plans. He has grown business effectiveness in an array of sectors and circumstances throughout Canada, consistently aligned with stakeholders goals and values.
Craig Lennox | CFO
Craig Lennox is a proven leader with an extensive background in financial management and operations. Mr. Lennox was most recently CFO at Clearly, a leading online optical retailer. He is a Chartered Professional Accountant and holds a Bachelor of Commerce degree from Queen’s University. He worked at Ernst & Young LLP in Toronto and Vancouver serving both public and private companies. Mr. Lennox spent over 5 years at The Jim Pattison Group Corporate Office in various senior financial roles. Mr. Lennox joined Clearly (Coastal Contacts Inc. – TSX listed) in 2012 as Vice-President of Finance where he was involved in building the business, listing the Company on the Nasdaq and in the ultimate sale of the company in April 2014 to Essilor for $430m. Mr. Lennox became Chief Financial Officer at Clearly in April 2014 and held that role until joining MYM.
Charith Adkar | CSO
Charith Adkar completed his PhD in Plant Biology and Crop Production from the University of Milano, Italy with the specialization in Molecular Plant Pathology. He has done his postdoctoral studies at Hirosaki University, Japan and Université de Sherbrooke, Canada. His areas of expertise include: Plant Science, Biotechnology, Microbiology, Molecular host-pathogen interactions and Bioinformatics. His career highlights include the development of molecular diagnostic kits for the detection of pathogens, studies on molecular basis of pathogenesis of non-coding RNAs. His work has featured in more than 45 scientific publications, a book chapter and a filed patent as a co-inventor. He has given several invited talks at national and international scientific meetings as well as at universities. He is a member of several international and national professional societies and serves as a scientific reviewer in high- impact biological science journals. He has received several prestigious fellowships such as Japan Society for promotion of Sciences (JSPS) Postdoctoral Fellowships for Foreign Researchers,Fondsqueb́ećoisdelarecherchesurlanatureetlestechnologies(FQRNT), Quebec, Canada. He also received the best research article award from the Phytopathological Society of Japan and Journal of General plant pathology for the research article for the year 2015
Edward Tabisz | Independent Director
Mr. Tabisz is an Executive with TD Bank with over 15 years experience in Retail Distribution, Product Management, Finance and Operations. Mr. Tabisz currently leads the Finance team supporting the Real Estate Secured Lending business. Prior to, as an executive with TD Insurance, he led the strategic development and change management of their Life and Health product suite, the culmination of which resulted in an industry Six Sigma process improvement award. Mr. Tabisz graduated from the University of Manitoba in 2001 with more recent on- going continuous learning through Schulich School of Business, York University Executive Education Centre. Mr. Tabisz joins MYM’s board of directors effective May 1, 2018.
Elizabeth Liu, QC | Independent Director
Ms. Elizabeth Liu founded and is Managing Director of LINK Business Law Group, a law firm that provides a broad range of legal, strategic and risk management advice, as well as general counsel services. Her clients include both early-stage and established companies in a variety of industries.
Prior to establishing LINK Business Law Group, Ms. Liu was Managing Partner at Basham Thompson & Liu LLP, a boutique litigation firm. She then served as Vice President and General Counsel to the Flora Group of Companies where she was involved in all aspects of the group’s operations and provided guidance on contracts and other legal and risk planning issues. Flora manufactures and sells premium natural health products and has numerous distributorships in international markets. Ms. Liu was appointed Queen’s Counsel by Order-in- Council in December 2016.
Joel Lalancette | Master Grower
Mr. Lalancette brings with him thirteen years of experience in the greenhouse industry. He is an integrated operator who has been a leader in establishing numerous greenhouse businesses. His most recent experience saw him establish himself as one of Quebec’s largest producers of microgreens. Mr. Lalancette has vast knowledge and experience in large-scale greenhouse projects and is an expert in multi-zone, computer-controlled climate systems, hydroponic, aeroponic, and traditional soil systems.
Fabian Garcia | Weedon Project Manager
Mr. Garcia brings with him 15 years of experience in the oil and gas and petrochemical industry. He has served in a number of senior roles including Area Manager, Operations Manager, and General Manager. Mr. Garcia has a strong background in strategic planning, operations, restructuring, business development, and project start-ups. He has lived and worked in China, Qatar, Iraq, UAE, United States, Italy and Canada. He has a degree in Business Administration Marketing from Bishop’s University. Mr. Garcia will be responsible for the planning and build out of the Weedon project effective immediately.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty nine hundred dollars for MYM Nutraceuticals Inc.current news coverage by a non-affiliated third party. FNMG HOLDS NO SHARES OF MYM Nutraceuticals Inc.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.